NASDAQ Composite ended the session with Catalyst Pharmaceuticals jumping 2.1% to $4.38 on Tuesday while nASDAQ Composite jumped 1.05% to $13,996.10.

Catalyst Pharmaceuticals today’s close was $4.38, 18.49% below its 52-week high of $5.19.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 3%, now sitting on 119.07M for the twelve trailing months.


Catalyst Pharmaceuticals’s last day, last week, and last month’s current volatility was 0.93%, 2.54%, and 3.43%, respectively.

Catalyst Pharmaceuticals‘s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.33% (day), 4.05% (last week), and 5.82% (last month), respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $4.38 at 17:18 EST, way below its 52-week high of $5.19 and way above its 52-week low of $2.88.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is above its 50-day moving average of $4.11 and way above its 200-day moving average of $3.63.

More news about Catalyst Pharmaceuticals.


Please enter your comment!
Please enter your name here